Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

Cited In for PubMed (Select 16014886)

1.

Age at First Delivery and Osteoporosis Risk in Korean Postmenopausal Women: The 2008-2011 Korea National Health and Nutrition Examination Survey (KNHANES).

Yun BH, Choi YR, Choi YS, Cho S, Lee BS, Seo SK.

PLoS One. 2015 May 6;10(5):e0123665. doi: 10.1371/journal.pone.0123665. eCollection 2015.

2.

Fractal lacunarity of trabecular bone and magnetic resonance imaging: New perspectives for osteoporotic fracture risk assessment.

Zaia A.

World J Orthop. 2015 Mar 18;6(2):221-35. doi: 10.5312/wjo.v6.i2.221. eCollection 2015 Mar 18. Review.

3.

Comparing the T scores from bone sonometer measurements in Hispanic and non-Hispanic white women.

Droege M, Marsh WA, Alvarez GN, Hunter TS.

Pharm Pract (Granada). 2006 Oct;4(4):179-82.

4.

Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss.

Kubota T, Namba N, Kurotobi S, Kogaki S, Hirai H, Kitaoka T, Nakajima S, Ozono K.

Clin Pediatr Endocrinol. 2006;15(3):101-7. doi: 10.1297/cpe.15.101. Epub 2006 Aug 2.

5.

Type 1 diabetes and osteoporosis: A review of literature.

Dhaon P, Shah VN.

Indian J Endocrinol Metab. 2014 Mar;18(2):159-65. doi: 10.4103/2230-8210.129105. Review.

6.

Serum osteoprotegerin concentration with strontium ranelate treatment for postmenopausal osteoporosis: an open, prospective study.

Ertorer ME, Bakiner O, Anaforoglu I, Sezgin N, Demirag NG, Tutuncu NB.

Curr Ther Res Clin Exp. 2007 Jul;68(4):217-25. doi: 10.1016/j.curtheres.2007.08.001.

7.

Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss.

Christy AL, D'Souza V, Babu RP, Takodara S, Manjrekar P, Hegde A, Rukmini MS.

Biomark Insights. 2014 Mar 3;9:1-6. doi: 10.4137/BMI.S13965. eCollection 2014.

8.

Osteoporosis risk prediction for bone mineral density assessment of postmenopausal women using machine learning.

Yoo TK, Kim SK, Kim DW, Choi JY, Lee WH, Oh E, Park EC.

Yonsei Med J. 2013 Nov;54(6):1321-30. doi: 10.3349/ymj.2013.54.6.1321.

9.

Evaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study.

Migliaccio S, Resmini G, Buffa A, Fornari R, Di Pietro G, Cerocchi I, Dormi A, Gimigliano F, Mulè R, Celi M, Frigato M, Lenzi A, Tarantino U, Iolascon G, Malavolta N.

Clin Cases Miner Bone Metab. 2013 Jan;10(1):56-60. doi: 10.11138/ccmbm/2013.10.1.056.

10.

Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications.

Pickhardt PJ, Pooler BD, Lauder T, del Rio AM, Bruce RJ, Binkley N.

Ann Intern Med. 2013 Apr 16;158(8):588-95. doi: 10.7326/0003-4819-158-8-201304160-00003.

11.

Hypercholesterolemia promotes an osteoporotic phenotype.

Pelton K, Krieder J, Joiner D, Freeman MR, Goldstein SA, Solomon KR.

Am J Pathol. 2012 Sep;181(3):928-36. doi: 10.1016/j.ajpath.2012.05.034. Epub 2012 Jul 4.

12.

Association between gait speed and bone strength in community-dwelling postmenopausal Japanese women.

Sakazaki T, Koike T, Yanagimoto Y, Oshida Y.

Environ Health Prev Med. 2012 Sep;17(5):394-400.

13.

What accounts for rib fractures in older adults?

Wuermser LA, Achenbach SJ, Amin S, Khosla S, Melton LJ 3rd.

J Osteoporos. 2011;2011:457591. doi: 10.4061/2011/457591. Epub 2011 Oct 19.

14.

Anamnestic risk factor questionnaire as reliable diagnostic instrument for osteoporosis (reduced bone morphogenic density).

Kolios L, Takur C, Moghaddam A, Hitzler M, Schmidt-Gayk H, Suda AJ, Höner B, Grützner PA, Wölfl C.

BMC Musculoskelet Disord. 2011 Aug 17;12:187. doi: 10.1186/1471-2474-12-187.

15.

Simultaneous screening for osteoporosis at CT colonography: bone mineral density assessment using MDCT attenuation techniques compared with the DXA reference standard.

Pickhardt PJ, Lee LJ, del Rio AM, Lauder T, Bruce RJ, Summers RM, Pooler BD, Binkley N.

J Bone Miner Res. 2011 Sep;26(9):2194-203. doi: 10.1002/jbmr.428.

16.

Association of hip strength estimates by finite-element analysis with fractures in women and men.

Amin S, Kopperdhal DL, Melton LJ 3rd, Achenbach SJ, Therneau TM, Riggs BL, Keaveny TM, Khosla S.

J Bone Miner Res. 2011 Jul;26(7):1593-600. doi: 10.1002/jbmr.347.

17.

Osteoporosis: "A risk factor for periodontitis".

Koduganti RR, Gorthi C, Reddy PV, Sandeep N.

J Indian Soc Periodontol. 2009 May;13(2):90-6. doi: 10.4103/0972-124X.55841.

18.

FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts.

Rached MT, Kode A, Xu L, Yoshikawa Y, Paik JH, Depinho RA, Kousteni S.

Cell Metab. 2010 Feb 3;11(2):147-60. doi: 10.1016/j.cmet.2010.01.001.

19.

Assessing forearm fracture risk in postmenopausal women.

Melton LJ 3rd, Christen D, Riggs BL, Achenbach SJ, Müller R, van Lenthe GH, Amin S, Atkinson EJ, Khosla S.

Osteoporos Int. 2010 Jul;21(7):1161-9. doi: 10.1007/s00198-009-1047-2. Epub 2009 Aug 28.

20.

Screening bone mineral density in epilepsy: a call to action, but what action?

Herman ST.

Epilepsy Curr. 2009 Mar-Apr;9(2):44-6. doi: 10.1111/j.1535-7511.2008.01288.x. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk